Primary effusion lymphoma (PEL) is a rare type of lymphoma that arises in the body cavity without detectable masses. It is associated with human herpes virus-8 (HHV-8), Epstein-Barr virus (EBV), and human immuno-deficiency virus (HIV). Recently, PEL unrelated to viral infection has been reported and it has been termed HHV-8 unrelated primary effusion lymphoma-like lymphoma (HHV-8 unrelated PEL-like lymphoma). Here, we report a case of HHV-8 unrelated PEL-like lymphoma in an 80-year-old woman. Chest X-ray and computed tomography revealed left-sided pleural effusion. Pleural effusion analysis and mediastinoscopic biopsy showed atypical cells that had originated from the B cells. The cells were positive for CD20 and bcl-2, but negative for CD3...
Primary Effusion Lymphoma (PEL) is a rare type of Non-Hodgkin’s Lymphoma caused by human herpesvirus...
Primary effusion lymphoma (PEL) is an unusual form of non- Hodgkin's lymphoma, which is characterize...
We described a case report of a 36-year-old woman with a 10-year-history of idiopathic CD4+ T-lympho...
Primary effusion lymphoma (PEL) is a very rare type of lymphoma usually confined to the body cavitie...
Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that presents with serosal ef...
lymphoma with BCL6 rearrangement in a patient with idiopathic CD4 positive T-lymphocytopenia Primary...
Primary effusion lymphoma (PEL) is defined by the WHO classification as a large B-cell neoplasm with...
Primary effusion lymphoma (PEL) is an unusual and rare type of non-Hodgkin's lymphoma characterized ...
Primary effusion lymphoma (PEL) is a B-cell neoplasm characterized by infection of the tumor clone b...
Primary lymphomatous effusions are defined as lymphomas presenting in the serous body cavities in th...
Primary effusion lymphoma (PEL) is a rare, aggressive B-cell lymphoma that usually localizes to sero...
Primary effusion lymphoma (PEL) is a distinct clinicopathologic entity associated with human herpesv...
ObjectivesTo report a patient with primary effusion lymphoma who was negative for human herpesvirus-...
Recent molecular evidence suggests an association with a new herpes virus, Kaposi‘s sarcoma-associa...
AbstractPrimary effusion lymphoma (PEL) is a distinct clinicopathologic entity associated with human...
Primary Effusion Lymphoma (PEL) is a rare type of Non-Hodgkin’s Lymphoma caused by human herpesvirus...
Primary effusion lymphoma (PEL) is an unusual form of non- Hodgkin's lymphoma, which is characterize...
We described a case report of a 36-year-old woman with a 10-year-history of idiopathic CD4+ T-lympho...
Primary effusion lymphoma (PEL) is a very rare type of lymphoma usually confined to the body cavitie...
Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that presents with serosal ef...
lymphoma with BCL6 rearrangement in a patient with idiopathic CD4 positive T-lymphocytopenia Primary...
Primary effusion lymphoma (PEL) is defined by the WHO classification as a large B-cell neoplasm with...
Primary effusion lymphoma (PEL) is an unusual and rare type of non-Hodgkin's lymphoma characterized ...
Primary effusion lymphoma (PEL) is a B-cell neoplasm characterized by infection of the tumor clone b...
Primary lymphomatous effusions are defined as lymphomas presenting in the serous body cavities in th...
Primary effusion lymphoma (PEL) is a rare, aggressive B-cell lymphoma that usually localizes to sero...
Primary effusion lymphoma (PEL) is a distinct clinicopathologic entity associated with human herpesv...
ObjectivesTo report a patient with primary effusion lymphoma who was negative for human herpesvirus-...
Recent molecular evidence suggests an association with a new herpes virus, Kaposi‘s sarcoma-associa...
AbstractPrimary effusion lymphoma (PEL) is a distinct clinicopathologic entity associated with human...
Primary Effusion Lymphoma (PEL) is a rare type of Non-Hodgkin’s Lymphoma caused by human herpesvirus...
Primary effusion lymphoma (PEL) is an unusual form of non- Hodgkin's lymphoma, which is characterize...
We described a case report of a 36-year-old woman with a 10-year-history of idiopathic CD4+ T-lympho...